Paris, France – The Global Medical Technology Alliance (GMTA), representing 26 leading international and regional medical technology associations including AdvaMed (the Advanced Medical Technology Association), today announced adoption of globally harmonized ethical business principles applicable across their respective member associations, as outlined in a joint statement.
Press Release | May 3, 2018
AdvaMed Congratulates Stryker’s Bronwen Taylor on Receiving 2018 PwC MedTech Ethical Leadership Award
Press Release | May 2, 2018
Paris, France – Bronwen Taylor, vice president, compliance and risk management at Stryker, was honored with the 2018 PwC Award for Leadership in the Advancement of Ethics in the Medical Device Industry.
Blog Post | April 20, 2018
Ensuring medical devices are shielded from cybersecurity threats is, in the words of the U.S. Food and Drug Administration, a "shared responsibility" among all stakeholders. Medical technology companies, hospitals, physicians, IT professionals, providers, regulators and patients all need to work together so that the safety and integrity of interconnected medical devices – everything from pacemakers and ICDs to monitors and infusion pumps – is not compromised due to cyber threats.
June 7, 2018 | Washington, DC
Save the date for a showcase highlighting life-changing innovation that is solving America’s most pressing health challenges. Date: June 7th, 2018 Time: 5:30pm – 7:30pm Location: Rayburn House Office... Read More
September 24, 2018 to September 26, 2018| Philadelphia, PA
The MedTech Conference is your opportunity to connect with thousands of medical technology professionals in one place, at one time. Join us in Philadelphia for business development, innovative... Read More
October 15, 2018 to October 16, 2018| Washington, DC
FDA and industry experts are coming together to teach you the basics of 510(k) submissions. This unique opportunity will help you better understand the FDA perspective on 510(k) submissions, from... Read More
October 17, 2018 | Washington, DC
Join us in Washington, D.C. where FDA and industry experts will come together to lead you through the regulatory and practical guidelines governing when an investigational device exemption (IDE) is... Read More
October 18, 2018 to October 19, 2018| Washington, DC
Join us in Washington, D.C. where FDA and industry experts will come together to lead you through the strategic considerations and practical steps of filing a Premarket Approval. This unique... Read More
Ricky Payne, a father of three, experienced a heart attack during his son's football game. Doctors were able to take stress off his heart and help with long-term recovery using life-changing medical technology.
Helius Medical Technologies, Inc. Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants
Helius Medical Technologies, Inc.
NEWTOWN, PA., April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions. The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States.
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.
May 18, 2018 - 3:50pm